Posts by Lynn Webster, M.D.
What Senator Ed Markey Doesn’t Understand
Senator Ed Markey of MA Opposed DSUVIA According to a recent USA Today article, Senator Ed Markey of Massachusetts “urged the FDA not to approve Dsuvia last month, saying “an opioid that is a thousand times more powerful than morphine is a thousand times more likely to be abused, and a thousand times more likely to…
Read MoreJournalists Jacob Sullum and Pat Anson Report on Two Important Topics
Medicare Rule Will Create New Challenges for Chronic Pain Patients Jacob Sullum recently wrote an article, “Medicare Rule Will Create New Challenges for Chronic Pain Patients,” for Practical Pain Management about the ways in which the pending Medicare changes will adversely affect chronic pain patients. As he explains, the new Medicare rule is intended to…
Read MoreBeyond Midterms
What’s Next? Midterms are behind us. You may be pleased or displeased with the results. Either way, the newly elected, and the reelected, senators and members of congress will now determine healthcare policy. They will take office in January. In the meantime, do your homework. When you’re worried that your doctor might be pressured to…
Read MoreGet Out to Vote
Vote to Change Healthcare Policies Mid-term elections are approaching. If you have the ability to vote, then this is a chance to help determine the direction of our healthcare policies. There are many issues important to each of us. To people who follow my blog, the most important healthcare issues have to do with how…
Read MoreSUPPORT for Patients and Communities Act
SUPPORT for Patients and Communities Act President Donald Trump signed the bi-partisan opioid legislation on October 24. According to Vox, the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act “is a big breakthrough that will boost access to addiction treatment and many other interventions to mitigate the…
Read MorePersonalized Pain Medicine
Below is an edited excerpt from a chapter titled, Pharmacogenetics and Personalized Medicine in Pain Management, that Inna Belfer, MD PhD and I published in Clinics in Laboratory Medicine, Volume 36, Issue 3, September 2016. Personalized Pain Medicine Pharmacogenetic therapy in people with pain requires consideration of 2 different genetic substrates to determine the outcome…
Read MoreMy Testimony Before the ADCOM for AcelRex’s DSUVIA
On Friday, Oct. 12, 2018, AcelRex Pharmaceuticals, Inc. presented its case to the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (ADCOM) to discuss the approval of the new drug application (NDA) 209128 for DSUVIA™. DSUVIA is a small sufentanil pill deposited below the tongue with an applicator. It is…
Read MoreHealth Professionals Call on the CDC to Address Misapplication of Its Guideline
Stefan G. Kertesz, MD Pens a Letter to the CDC Health Professionals Call on the CDC to Address Misapplication of Its Guideline on Opioids for Chronic Pain through Public Clarification and Impact Evaluation by Health Professionals for People in Pain is a letter that I recently had the privilege of signing. (Click here to see…
Read MoreFootball and Brain Trauma
Football’s Risks It’s just a “ding,” the coach would tell the parents. “He will be fine. He needs to be a man and get tougher. Everything is fine.” This is what I heard growing up in a place where football was valued more than religion. In fact, it was our religion. Unfortunately, we now know…
Read MoreDetecting the Liar
Discerning Lies Can Be Challenging According to Scientific American Mind, lying “is among the most sophisticated accomplishments of the human mind.” It requires cognitive skills that children are not born with and must acquire. Our ability to lie seems to improve until we reach young adulthood, and then it levels off. Once we reach about…
Read More